Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - ARGOS THERAPEUTICS INC | exh_312.htm |
| EX-32.1 - EXHIBIT 32.1 - ARGOS THERAPEUTICS INC | exh_321.htm |
| EX-31.1 - EXHIBIT 31.1 - ARGOS THERAPEUTICS INC | exh_311.htm |
| EX-10.31 - EXHIBIT 10.31 - ARGOS THERAPEUTICS INC | exh_1031.htm |
| EX-10.30 - EXHIBIT 10.30 - ARGOS THERAPEUTICS INC | exh_1030.htm |
| 10-K - FORM 10-K - ARGOS THERAPEUTICS INC | f10k_033016p.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-195223 and 333-208055) and Form S-3 (No. 333-204016) of Argos Therapeutics, Inc. of our report dated March 30, 2016 relating to the financial statements and financial statement schedule, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
March 30, 2016